Borealis Biosciences’ $150 Million Series A Financing Round

Wilson Sonsini Goodrich & Rosati advised Borealis Biosciences on the transaction.Borealis Biosciences (Borealis), a next-generation RNA medicines company, emerged from stealth with $150 million in combined…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here